News and Comments

INOVIO: PROMISING RESULTS OF THE FIRM VGX-3100 HPV THERAPEUTIC VACCINE

  Wednesday, July 30, 2014

INOVIO More...

EXELIXIS: TIME FOR TRANSFORMATION. THE BEST IS YET TO COME

  Wednesday, July 16, 2014

We stayed with Exelixis (EXEL) In spite of the negative articles that made this firm look as if planting seeds in the ocean. Investors acted as if condemning the firm’s efforts, its small molecule drug design technology and its investigational oncology products. We remained fans in spite of the complete paralysis of the stock for a long time. We always believed that all the negatives about this firm measure little compared to its positives. More...

JAZZ PHARMACEUTICALS: WHY INVESTORS EXCITEMENT?

  Monday, July 07, 2014

Jazz Pharmaceuticals’ (JAZZ) surged following the announcement that it has signed a definitive agreement with Sigma-Tau Pharmaceuticals to acquire the rights for the Americas to the drug defibrotide. JAZZ gained $10 on Wednesday July 2 and added another $0.80 on Thursday July 3 after a brief profit taking. The stock ended the week of the 4th of July trading at $162.82, rebounding from a selloff resulting from analysts’ downgrades in the name of stock price correction.     More...


Recent Postings


Archive


Tags

LEXICON (LXRX) RenenxBio (RGNX) Micromet (MITI) Idenix (IDIX) OncoCyte (OCX) CRISPR Therapeutics (CRSP) NANTKWEST (NK) Intercept (ICPT) Aimmune Therapeutics (AIMT) Agenus (AGEN) Ionis (IONS) BIOMARIN (BMRN) Illumina (ILMN) Mirati Therapeutics (MRTX) Gilead (GILD) Galena (GALE) JUNO (JUNO) Rapamune Elan (ELN) Amgen (AMGN) Dynavax (DVAX) Ridaforolimus Zerenex Jazz Pharmaceuticals (JAZZ) SERES THERAPEUTICS (MCRB) Vertex (VRTX) INNOVIVA (INVA) Intrexon (XON) PTC Therapeutics (PTCT) Sequenom (SQNM) ARCA (ABIO) Sarepta (SRPT) Spike Therapeutics (ONCE) PORTOLA (PTLA) Theravance Bio Pharma (TBPH) Bellicum (BLCM) Editas (EDIT) Biogen Idec (BIIB) TOKAI (TKAOI) Sangamo (SGMO) NEUROCRINE (NBIX) NOVOCURE (NVCR) NEKTAR (NKTR)) Revlimid (lenolidamide) Adaptimmune (ADAP) Sanofi (SNA) CompuGen (CGEN) Pluristem (PSTI) ISIS (ISIS) Valeant Pharmaceuticals International (VRX) CEMPRA (CEMP) Abbott Laboratories (ABT) Advaxis (ADXS) Multiple Myeloma Xoma (XOMA) Alder Biopharmaceuticals (ALDR) Sanofi (SNY) Dendreon (DNDN) C4 Therapeutics ABBVIE (ABBV) SUNESIS PHARMACEUTICALS (SNSS) KITE (KITE) ADVENTRIX (ANX) AERIE PHARMACEUTICALS Roche (ROCHE) Agenus (AGEN Incyte (INCY) SYNTA (SNTA) VANDA (VNDA) Anacor (ANAC) Vitae Pharmaceuticals (VTAE) Inovio (INO) Velcade (bortezomib) Cytokinetics (CYTK) Theravance (THRX) Roche (RHHBY) ARGOS (ARGS) Global Cell Therapeutics (GBT) Genentech MODERNA Regeneron (REGN) Ariad (ARIA) Intermune (ITMN) Seattle Genetics (SGEN) Biocryst (BCRX) galapagos (GLPG) Tysabri GUARDIAN HEALTH Merck (MRK) Ocular Therapeutix (OCUL) AGOS (ARGS) Prosensa (RNA) Herceptin KERYX (KERX) GlaxoSmithKline (GSK) Array Pharmaceuticals (ARRY) Auspex (ASPX) JOUNCE THERAPEUTICS (JNCE) ACADIA (ACAD) Sanofi-Aventis (SAN) Onyx (ONXX) Benlysta (belimumab) Trastuzumab-DM1 Alnylam (ALNY) REGULUS (RGLS) Human Longevity (HLI) Ziofpharm (ZIOP) Endometrial Cancer Telaprevir Exelixis (EXEL) OSI (OSIP) HALOZYME (HALO) ImmunoGen (IMGN) Bristol-Myers Squibb (BMY) IDERA (IDRA) ZALTRAP™ Anadys (ANDS) Prolor Biotech (PBTH) Human Genome Sciences (HGSI) AstraZeneca (AZN)